Aleafia Health Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Aleafia Health Inc. - overview

Established

2007

Location

Concord, ON, Canada

Primary Industry

Healthcare

About

Aleafia Health Inc. is a Canadian-based company focused on the cultivation and distribution of high-quality cannabis products for medical and recreational consumers, offering a diverse range of products tailored to various health needs and lifestyle preferences. Founded in 2007 in Concord, Canada, Aleafia Health Inc. specializes in the cannabis sector, providing products designed for both medical and recreational use.


The company has undergone strategic pivots to adapt to market demands. With a total of three deals, their most recent funding round, a Private Placement on June 24, 2022, raised CAD 5. 60 million, matching their total amount raised of CAD 5. 60 million.


The company is led by CEOs Geoff Benic and Tricia Symmes. Aleafia Health Inc. focuses on cultivating and distributing high-quality cannabis products, including oils, edibles, and dried flowers, designed to meet the needs of medical patients and recreational users. The company’s offerings are tailored to address specific health concerns and lifestyle choices, with sales across Canada and select international markets, emphasizing quality and innovation in the cannabis sector.


In the most recent year, 2019, Aleafia Health Inc. generated revenue of CAD 12,365,600 and reported an EBITDA of CAD -14,050,400 in 2018, reflecting the financial dynamics of their operations during that period. Aleafia Health Inc. is focused on expanding its product line and market reach.


The company is working on new product launches aimed at enhancing their portfolio by targeting additional health-related needs. Plans to enter new geographical markets are also underway, with specific focus on regions that align with their product offerings by 2023. The recent funding of CAD 5. 60 million will be utilized to support these initiatives, with a portion directed towards product development and market expansion strategies.


Current Investors

Serruya Private Equity

Primary Industry

Healthcare

Sub Industries

Alternative Medicine, Crop Production

Website

www.aleafiainc.com

Verticals

Cannabis/Medical Marijuana, Manufacturing

Company Stage

Mature

Total Amount Raised

Subscriber access only

Aleafia Health Inc. - financials

Fiscal Year EndedDec 31, 2017Dec 30, 2018Dec 30, 2019
Revenue (USD)---
% Revenue Growth (YoY)---
EBITDA (USD)---
Operating Income (USD)---
Operating Margin---
% EBITDA Margin---
NET Income (USD)---
% Net Margin---

Aleafia Health Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Private Placement/Follow onCompletedAleafia Health Inc.-
Private Placement/Follow onCompletedAleafia Health Inc.-
Add-onCompletedEmblem Corp. -
PIPECompletedAleafia Health Inc.-

Displaying 1 - 4 of 4

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.